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10 The Journal of Thoracic and Cardiobjective: The invention of robotic systems has begun a new era of endoscopic car-
iac surgery. Reports on totally endoscopic coronary artery bypass grafting are limited,
owever, and data regarding feasibility, safety, and efficacy are needed to determine this
echnique’s position in the therapeutic armamentarium. This study describes the largest
ulticenter experience in the literature with robotic totally endoscopic coronary artery
ypass grafting specifically addressing procedural feasibility, safety, and efficacy.
ethods: Between September 1998 and November 2002, a total of 228 patients with
oronary artery disease were scheduled for totally endoscopic coronary artery
ypass grafting with the da Vinci Surgical System (Intuitive Surgical Inc, Sunny-
ale, Calif.) at five European institutions. Patients underwent totally endoscopic
oronary artery bypass grafting with either an on-pump (group A, n  117) or an
ff-pump approach (group B, n  111). Patients underwent postoperative angiog-
aphy or stress electrocardiography and were followed up for 6 months.
esults: Procedural feasibility was demonstrated through the completion of 164
uccessful totally endoscopic cases. Sixty-four patients (group C, 28%) had con-
ersion to nonrobotic procedures. Conversion rates decreased with time. The overall
rocedural efficacy, as defined by angiographic patency or lack of ischemic signs on
tress electrocardiography, was 97%. The incidence of major adverse cardiac events
ithin 6 months was 5%.
onclusion: Both on- and off-pump totally endoscopic coronary artery bypass
rafting are feasible, with a conversion rate that diminishes with increasing expe-
ience. Conversion does not adversely affect outcome and thus constitutes a safe
lternative. Although target vessel reintervention may be slightly higher than that
eported for open coronary artery bypass grafting, graft patency and major adverse
ardiac events for both approaches are comparable to those reported in the Society
f Thoracic Surgeons database, demonstrating the safety and efficacy of the totally
ndoscopic coronary artery bypass grafting procedure.
 
he continuous refinement of coronary artery bypass grafting (CABG) ha
to a mature and efficient procedure that provides excellent long-term results
for selected patients, with low mortality.1,2 Standard CABG, however, 
ssociated with significant invasiveness and large social, direct, and indirect c3
hese limitations mandate further improvement. A novel procedure that uses robotic
echnology has been recently introduced into the operating room, enabling the
erformance of endoscopic coronary surgery.4 This procedure potentially offers t
enefits of endoscopic surgery: avoidance of an aggressive chest incision, minimal
vascular Surgery ● September 2007
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ETlood–air interface, and minimal risk of infection, with a
etter cosmetic result and faster recovery and return to
outine activity. Robotic surgery represents a major para-
igm shift and challenge for the operative team.5 It requires
he development of new technical skills, communication
atterns, and conversion and contingency modalities, as
ell as overall changes in operative planning.6-8 Since the
orld’s first procedure at the end of 1998, only limited
atient numbers have been reported from single-center
eries.
This report describes the largest multicenter experience
o date with robotic totally endoscopic CABG (TECAB). It
pecifically addresses feasibility, safety, and efficacy while
iscussing the potential value and limitations of TECAB.
aterials and Methods
etween September 1998 and November 2002, a total of 228
atients aged 18 to 80 years (59.2  10.1 years) with significant
ymptomatic coronary artery disease were selected to undergo
ECAB with the da Vinci Surgical System (Intuitive Surgical Inc,
unnyvale, Calif) at five European institutions. The patients were
ategorized into three groups: on-pump TECAB (group A, 1.9 
.8), off-pump TECAB (group B, 1.9  0.8), and conversions
group C, 2.0  0.8). A conversion was defined as the need for an
ncision (sternotomy or minithoracotomy) before the completion
f the endoscopic anastomosis. A reintervention, even during the
ame operative session, after the completion of the anastomosis
as been regarded as a major adverse cardiac event (MACE). All
atients underwent 6-month postoperative follow up. In consider-
ng patients suitable for a robotic operation, the following exclu-
ion criteria were applied: evidence of severely calcified left an-
erior descending coronary artery, contraindications for peripheral
annulation (group A), morbid obesity, decompensated congestive
eart failure, and acute renal failure.
Overall, the vast majority (90%) had single-vessel disease, with
he target vessel for revascularization being the left anterior de-
cending coronary artery in 86%, a diagonal branch in 3%, and the
ight coronary artery in 1%. The remaining patients received either
sequential left internal thoracic graft to the diagonal and left
nterior descending arteries (6%) or a double thoracic graft to the
eft anterior descending artery and the circumflex artery, diagonal,
r right coronary artery (4%). Sixty percent had a history of
ercutaneous intervention to the left anterior descending artery
efore TECAB, whereas 15% underwent TECAB as a part of a
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
CPB  cardiopulmonary bypass
ECG  electrocardiography
MACE major adverse cardiac event
STS  Society of Thoracic Surgeons
TECAB totally endoscopic coronary artery bypass
graftingybrid procedure. All institutions completed the majority of their a
The Journal of Thoracicn-pump TECAB experience (group A) before proceeding to their
ff-pump TECAB experience (group B) and performed at least 30
ases. In group A, the left internal thoracic artery was harvested,
he pericardium was opened, and the target vessel was identified
efore femoral cardiopulmonary bypass was instituted. The oper-
tive techniques have been described previously.9,10 In group A
he CABG was performed under endoaortic balloon clamping and
ardioplegic arrest, with a running suture to anastomose the tho-
acic conduit to the target vessel. In group B, an endoscopic
tabilizer was inserted through a subxyphoid port after the thoracic
arvesting and pericardial opening for stabilization of the target
essel and performance of the anastomosis on the beating heart.
All the operations were performed after obtaining written in-
ormed consent from the patient, in accordance with the ethics
ommittees of each participating institution.
easibility, Efficacy, and Safety Assessment
he feasibility of the procedure was assessed by the ability to
uccessfully complete TECAB without the need for conversion to
ny kind of open-chest procedure. The rate, reasons, and evolution
f conversions are described in Tables 1 and 2 and in Figure 
fficacy of the procedure was measured by postoperative angiog-
aphy, stress electrocardiography (ECG), or both. Angiographic
fficacy was defined with a modified FitzGibbon criteria of less
han 50% stenosis of the distal anastomosis for a patent graft. A
linically negative stress test result for ECG, defined by the ab-
ence of angina and ST-wave changes, was used as a surrogate
easure for graft patency. Procedural safety was measured by the
ncidence of MACEs within a 6-month postoperative period.
ACE variables included all-cause mortality, myocardial infarc-
ion, and target vessel reintervention. Perioperative incidence of
ACE was compared with that in a matched cohort from the
ociety of Thoracic Surgeons (STS) National Database for open
hest procedures performed for isolated single-vessel disease be-
ween 2000 and 2002. To assess longer term recurrence of
ACEs, a random sample of 100 patients was contacted during
he reviewing period of the article, at an average follow-up of 3.5
ears.
ata Collection, Entry, and Analysis
ata were abstracted from medical charts and covered a 6-month
ollow-up period for completion of the study. Clinical information
as verified against medical records by three independent moni-
ors. Once entered in a database and verified for accuracy, the data
ere accessed and analyzed with SAS (SAS Institute, Cary, North
arolina) statistical software.
tatistical Methods
he study was designed and powered to achieve an overall pro-
edural efficacy of 94%, with a lower limit of the 95 percent
onfidence interval of at least 90%. All analyses were conducted
ccording to an intent-to-treat principle. The data provided from
he STS National Database used for perioperative comparisons of
ACE frequency were based on a custom query of a patient
opulation undergoing sternotomy CABG for isolated single-ves-
el disease. Patients were matched on the basis of age, sex, and
reoperative risk factors. Although this comparison is provided as
baseline reference, it is not possible to draw meaningful statis-
and Cardiovascular Surgery ● Volume 134, Number 3 711
t
p
r
C
p
a
A
f
R
A
O
t
d
a
c
a re no
s
a
t Most
c
c
s
t
t
i e for
f
F
v
s
T
m
I
G
G
T
A
c
s
g .
T
R
T
C
P
B
I
d
T
W
A
d
d
Evolving Technology de Cannière et al
7
ETical comparisons because of demographic differences of the two
opulations. Patients who did not undergo postoperative angiog-
aphy or stress ECG were excluded from the efficacy analysis.
ategorical variables are expressed as number and percentage of
atients and were analyzed with the Fisher exact test or 2 test for
ssociation, with or without continuity correction.
Continuous variables were compared with a two-sample t-test.
log–rank test was used to compare Kaplan–Meier curves of
reedom from MACE.
ABLE 1. Intended totally endoscopic coronary artery byp
odes and incisions
ntended total procedures Nonconverted (TECAB) Total converte
roup A (n  117) 90 (77%) 27 (23%*)
roup B (n  111) 74 (66.7%) 37 (33.3%*)
ECAB (n  228) 164 (72%) 64 (28%)
ll data represent numbers and percentages of patients. TECAB, Totally e
oronary artery bypass grafting; CABG, on-pump coronary artery bypass
ignificant difference was seen in conversion rates between group A an
roup A. ‡This is the percentage of attempted procedures among group B
ABLE 2. Conversion reasons by procedure type
Conversions
eason for conversion Group A Group B Total
otal conversions 27 37 64
annulation 15 — 15 (23.4%)
Balloon failure (rupture or
migration)
9 — 9 (14.1%)
Iliofemoral condition 6 — 6 (9.4%)
atient conditions 3 22
Inability to locate and dissect
LAD
3 8 11 (17.2%)
Ventricular tachycardia — 1 11(1.7%)
Inadequate LITA flow — 1 1 (1.7%)
Hemodynamic instability — 3 3 (4.8%)
Calcified LAD — 7 7 (11%)
Body habitus 2 1 (1.7%)
leeding 6 8
Anastomotic site 6 6 12 (18.8%)
LITA — 1 1 (1.7%)
Right ventricle — 1 1 (1.7%)
nadequate stabilization — 6 6 (9.4%)
a Vinci System failure 1 1 2 (3.4%)
hreshold of time on CPB reached 1 — 1 (1.7%)
rong target vessel 1 — 1 (1.7%)
ll data represent numbers and percentages of patients. LAD, left anterior
escending coronary artery; LITA, left internal thoracic artery; CPB, car-niopulmonary bypass.
12 The Journal of Thoracic and Cardiovascular Surgery ● Septeesults
total of 228 subjects were intended to undergo TECAB.
ne hundred sixty-four patients underwent completion of a
otally endoscopic operation, whereas 64 patients (28%),
enoted as group C, had intraoperative conversion to an
lternate (nonrobotic) technique for completion of the pro-
edure. The total numbers of patients, stratified by group
nd conversion mode, are shown in Table 1. There we
ignificant differences in conversion rate between groups A
nd B. The individual reasons for conversion among pa-
ients in group A and B are explained in Table 2. 
onversions in group A were due to cannulation, whereas
onversion in group B occurred as the result of inadequate
tabilization, inappropriate patient conditions, or bleeding at
he anastomosis. The evolution of the conversion rates
hrough discrete 6-month time intervals for the study period
s shown in Figure 1. Twelve patients were unavailabl
ollow-up within the 6 month period.
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igure 1. Operation period represents 6 discrete 8-month inter-
als in which on-pump (group A) and off-pump (group B) conver-
ion rates are shown. Numbers in histogram represent total
rafting procedures and conversions to alternate surgical
Conversion mode
Thoracotomy Sternotomy
Arrested heart
Beating heart
(MIDCAB)
Arrested heart
(CABG)
Beating heart
(OPCAB)
6 (5.1%†) 14 (12%†) 4 (3.4%†) 3 (2.5%†)
— 34 (30.6%‡) 3 (2.7%‡) —
— — — —
opic coronary artery bypass grafting; MIDCAB, minimally invasive direct
ting; OPCAB, off-pump coronary artery bypass grafting. *No statistically
up B (P  .08). †This is the percentage of attempted procedures amongass g
d
ndosc
graf
d groumber of cases performed during period.
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ETThe efficacy of the TECAB procedure, as measured by
he FitzGibbon definition of patency (50% stenosis), was
6%, described in Table 3 for patients without conver
ostoperative angiographic controls were not systematically
erformed except in the case of hybrid procedures. One
undred grafts were assessed in 93 patients who did not
ave conversion; 17 grafts were assessed in 15 patients who
ad conversion (group C). Among patients who did not
ndergo angiography, 48 had completed a stress ECG test.
he overall efficacy of TECAB as assessed by stress test
lone was 98%. The combined procedural efficacy, as de-
ned for patients having had either test, was 97% for all
atients undergoing TECAB. In patients who had conver-
ion, the combined procedural efficacy was 97.7%. There
ere no statistically significant differences in procedural
fficacy across the three groups.
The safety of the TECAB procedure is depicted in a
eries of Kaplan–Meier curves in Figure 2 for on-
ff-pump procedures. There was no statistical differences in
he 6-month freedom from MACE between groups A and B
P  .64), groups A and C (P  .09), and groups B and C
P  .26). The same was true when group B was compared
ith group C (P  .26). Perioperative safety of the proce-
igure 2. Kaplan–Meier curves for 6-month freedom from major
dverse cardiac events (MACEs). Log–rank test shows no differ-
nce between groups A and B (P  .64), nor groups A and C (P 
ABLE 3. Procedure efficacy as measured by angiography
atient group
Patients with angiography
or stress test Per angiogra
roup A (n  90) 78 61/62 (98.4%
roup B (n  74) 63 35/38 (92.1)
verall (A  B) 141 100
roup C (n  64) 44 15/17 (88.2)
Among 55 patients, 62 grafts were assessed. †Among 38 patients, 38 gra
core among 15 group A patients: preoperative, 1.9  0.8; postoperative,
.8; postoperative, 0.05  0.2. Mean CCSC score among 15 group B patiem26), nor groups B and C (P  .09).
The Journal of Thoracicure was further compared with open chest procedures from
he STS National Database for isolated single-vessel disease
etween 2000 and 2002. This comparison was stratified by
n- and off-pump procedures. Nine of 164 patients without
onversion (5%) had a MACE within the 6-month postop-
rative period. Four of these events happened in group A
4%) and 5 in group B (7%). Among patients who had
onversion, 3 of 64 had a MACE (5%). The rates of peri-
perative target vessel reintervention appear to be higher for
ll TECAB groups relative to those for open CABG as
ublished in the STS National Database (Table 4); howe
tatistically meaningful conclusions cannot be drawn.
Overall, 3 patients without conversion (2%) died in the
erioperative period. In group A, mortality was 1%. One
atient died approximately 10 months after the operation
rom immunosuppressive therapy complications after kid-
ey transplantation. In group B, mortality was 3%. One
atient scheduled for a hybrid procedure died of an acute
nfarction in the territory of the circumflex artery before the
lanned percutaneous intervention could be performed. The
ause of death and the patency of the left anterior descend-
ng artery bypass were confirmed at necropsy. One patient
ied of major, acute gastrointestinal bleeding with shock
nd cardiac arrest that led to postanoxic coma after cardio-
ulmonary resuscitation. Among patients who did not have
onversion, mortality was 3%. The overall mortality of the
hree groups combined was 2.1%, versus a rate of 2.4% for
pen CABG.
Two patients (1%, 1 in group A and 1 in group B) had a
yocardial infarction within 7 days after the operation.
yocardial infarction rates did not statistically differ across
roups A and B and did not exceed the rates found with
pen CABG. Six patients underwent target vessel reinter-
ention in the 6-month postoperative period. Five under-
ent surgical reintervention; the remaining patient under-
ent stent placement. Of the reinterventions, 2 occurred in
roup A, 3 in group B, and 1 in group C (2%, 4%, and 1%,
espectively). There was no statistically significant differ-
nce in the incidence of target vessel reintervention. At a
stress electrocardiography
Efficacy
Per stress test
Per both angiography and
stress test
Patients not
assessed
23/23 (100%) 84/85 (98.8%) 12
24/25 (96) 59/63 (93.6) 11
48 148 23
28/28 (100%) 43/44 (97.7%) 20
re assessed. ‡Among 15 patients, 17 grafts were assessed. Mean CCSC
0.2. Mean CCSC score among 15 group B patients: preoperative, 1.9 
reoperative 2.0  0.8, postoperative 0.06  0.3.and
phy
)*
†
‡
fts we
0.02 ean follow up of 3.5 years of 100 randomly selected
and Cardiovascular Surgery ● Volume 134, Number 3 713
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ETatients, 4 had MACEs: 2 underwent percutaneous coronary
ntervention of a nontarget vessel, 1 had a myocardial in-
arction, and 1 had died from an unknown cause. No patient
ad undergone surgical target vessel reintervention.
iscussion
his study is limited by its retrospective nature and provi-
ion of only a 6-month follow up. It represents a multicenter
ollaboration in which 228 patients underwent TECAB. Its
urpose was to demonstrate feasibility, efficacy, and safety
f the endoscopic procedure on both the arrested and beat-
ng heart. A significant learning curve was observed. Pa-
ency rates and 6-month freedom from MACE revealed
cceptable results which were comparable to those from the
TS National Database. Although the institutions continue
o perform TECAB, the period of September 1998 through
ovember 2002 represents that in which the study took
lace and a sufficient sample size was obtained to study
raft patency and safety of the procedure, as requested by
he regulatory approval. Although patients in this study may
n fact have had longer follow up available, the 6-month
ime frame was chosen as a reasonable point within which
ACEs and graft patency would be assessed.
TECAB represents a new challenge, requiring develop-
ent of technical ability to work in an endoscopic environ-
ent. A conversion strategy and contingency plan therefore
ust be choreographed to bring the operation back to the
urgical standards in case of need.11
In the on-pump group (group A), which required femoral
annulation and endoaortic balloon clamping, 55% of the
onversions were related to cannulation issues and were
elated to neither the da Vinci system nor the endoscopic
ature of the operation itself. The management and moni-
oring of the endoaortic balloon clamp were made awkward
n the presence of the da Vinci system and generated sig-
ABLE 4. Major adverse cardiac events by procedure type
Overall
atient group
No. 228
Total/STS National Database* 20:48
ll cause mortality
Study, all causes 5 (2.1%)
STS National Database 494 (2.4%)
erioperative (7 d) myocardial
Study 2 (0.9%)
STS National Database 169 (0.8%)
arget-vessel reintervention (30 d)
Study 6 (2.6%)
STS National Database 60 (0.3%)
A, Not available; STS, Society of Thoracic Surgeons. *Society of Thora
rtery bypass grafting on pump (vs A) and off-pump (vs B) with matchedificant ”strategic” issues, such as the sequence of cannula s
14 The Journal of Thoracic and Cardiovascular Surgery ● Septensertion and anticoagulation with regard to the robotic
teps of the procedure. This contributed to an unexpectedly
igh rate of conversion for surgical teams with significant
ndoscopic CABG experience.12,13 Such conversions migh
ave been categorized as intraoperative exclusions, never
estined to be completed robotically, resulting in a signifi-
antly lower conversion rate; however, they are reported as
onversions per our intent-to-treat principle and represent
n evolutionary process.
In group B, 3 of 4 conversions were related to the target
essel (wall calcification, intramyocardial course, bleeding
rom the arteriotomy, and inadequate stabilization). It is
ikely that the small percentage of hemodynamic intolerance
n group B (4.8%) was due to a combination of factors
pecific to this procedure: the coexistence of carbon dioxide
nsufflation and stabilization, coupled with some degree of
ypoxemia in the event of single-lung ventilation with insuf-
cient compensation, and a potentially longer period of target
essel occlusion.14 With the exception of hemodynamic ins-
ility, which may be present in a fixed percentage of cases,
ther reasons for conversion can be specifically addressed. A
ignificantly improved endoscopic stabilizer has been a con-
iderable asset for the global success of the procedure. Target
essel localization is improving with time with the develop-
ent of endoscopic skills, and specific navigation software is
urrently under development to facilitate target vessel identi-
cation.15 Special silicone elastomer snares have been -
igned to minimize bleeding at the arteriotomy site. Conver-
ion modalities were different in groups A and B (Tab
ourteen of 27 conversions in group A were performed off-
ump through a lateral thoracotomy, whereas 34 of 37 patients
n group B had conversion to a lateral thoracotomy off-pump
rocedure. This conversion modality, known as robotically
nhanced minimally invasive direct coronary artery bypass
rafting, is regarded by some authors as the best operation for
Group A Group B Group C
90 74 64
11:382 9:106 NA
1 (1.1%) 2 (2.2%) 2 (2.31%)
279 (2.4%) 215 (2.4%) —
1 (1.1%) 1 (1.2%) —
92 (0.8%) 92 (0.8%) —
2 (2.2%) 3 (4.1%) —
26 (0.2%) 34 (0.4%) —
rgeons National Database 2000 through 2002 for single-vessel coronary
tratification.cic Suingle left anterior descending revascularization.16 It is note-
mber 2007
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ETorthy that 54 of the 64 patients with conversions (84%)
eceived a minimally invasive operation. Although the partic-
pating centers initially started with on-pump TECAB, this
rocedure was later abandoned in favor of off-pump TECAB
n the case of single-vessel revascularization.
The efficacy of surgical revascularization can be ad-
ressed in different ways. The criterion standard is the
ngiogram demonstrating graft patency, eventually com-
ined with a surrogate assessment of the functional com-
leteness of revascularization confirming the adequacy of
he therapeutic plan.17 The overall rate of TECAB proc-
ural efficacy was 97%. It did not vary significantly be-
ween groups A and B, confirming that it is effective and
ithin the expected range for a thoracic to left anterior
escending graft.18,19 Furthermore, the postoperative outcome
f the patients are unchanged regardless of whether the proce-
ure is endoscopic or converted to an alternate technique.
The specific skills that are required to perform an endo-
copic anastomosis on an arrested heart can easily be de-
eloped on isolated animal hearts. Training on such models
as taken place at each institution. On the other hand,
heoretic concerns have been raised about the efficacy of
ff-pump TECAB.20 The interposition of the robotic syste
ntroduces a delay between the surgical gesture and the
otion of the telemanipulated instrument. This delay theo-
etically affects the precision of tasks performed on the
eating heart, such as suture placement, so that even with an
dequate visualization of the suture line, the quality of the
nastomosis might be in question. This theoretic drawback
annot be solved unless perfect stabilization is achieved. It
ay also be overcome with the venue of anastomotic connec-
ors that are currently under clinical development. The results
f off-pump TECAB, however, as addressed through angio-
raphic controls, have been shown to be satisfactory and to fall
ithin the expected range for thoracic grafting.18,19 With con-
dence limits of combined efficacy ranging from 91% to
00%, off-pump TECAB is a viable therapeutic option.
The assessment of procedural safety shows that the in-
idence of MACE was similar between groups. Direct com-
arison of the overall incidence of MACE with that in the
TS database is difficult because of the unknown multiplic-
ty of coexisting adverse events among patients in the STS
atabase. This comparison is for information purposes until
rospective, randomized procedures are available. It needs
o be mentioned that it takes place in the learning curve of
ECAB, that the STS cohort is matched for the on and off
ump cases but includes only single bypasses and that the
atients of the TECAB cohort may have been followed up
ore closely, so that the comparison may be the worse case
cenario for TECAB. Mortality and myocardial infarction
re not affected by the endoscopic approach versus the STS
atabase. On the other hand, concerns regarding a poten-
ially higher incidence of target vessel reintervention for
The Journal of Thoracicndoscopic procedures must be weighed against the benefits
f a minimally invasive approach. In the longer term, the
lace of the totally endoscopic procedures in the therapeutic
rmamentarium against coronary artery disease will also
equire comparison to the existing alternatives of CABG
uch as the robotic-enhanced minimally invasive direct
ABG or ACAB.16
onclusions
lthough endoscopic CABG represents a major paradigm
hange, leading to difficulties that must not be underesti-
ated, the results of this study demonstrate that on-pump
nd off-pump TECAB are feasible, with a conversion rate
hat diminishes with increasing experience. Conversion
oes not adversely affect outcome and thus constitutes a
afe alternative. Although the rate of target vessel reinter-
ention may be slightly higher than that reported for open
ABG, graft patency and major adverse cardiac events for
oth approaches are comparable to those reported in the
TS database and demonstrate that TECAB is a safe and
ffective procedure. Future prospective studies and longer
ollow-up may address the benefits of successful TECAB
ith respect to conventional CABG.
Dr de Cannière thanks the Fonds pour la Chirurgie Cardiaque
nd LIVE for supporting the robotic program at Erasme Hospital.
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